MHRA Class 2 Medicines Recall: Phenobarbital 60mg tablets (Bristol Laboratories Limited)
MHRA Class 2 Medicines Recall: Phenobarbital 60mg tablets (Bristol Laboratories Limited)
June 13, 2022
Class 2 Medicines recall: Phenobarbital 60mg tablets (Bristol Laboratories Limited)
Drug alert number: EL (22) A/28
Date issued: 13th June 2022
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall for:
Phenobarbital 60mg tablets (Bristol Laboratories Limited)
Bristol Laboratories Limited are recalling the above batch of product as a precautionary measure due to low dissolution test results reported during ongoing stability studies.
| Batch Number | Expiry Date | Pack Size | First Distributed |
| NW0001 | December 2022 | 28 | 30 September 2020 |
Advice for healthcare professionals
Stop supplying the above batch immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.
Full drug alert can be viewed here.
Company contacts for further information
For more information, medical or supply enquiries, please contact notifications@bristol-labs.co.uk.
Posted in: Dispensing & Supply
